{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 10012, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T01:29:13Z", "timestamp": 1574213353978}, "reference-count": 52, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 6, 17]], "date-time": "2006-06-17T00:00:00Z", "timestamp": 1150502400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2006, 8]]}, "DOI": "10.1007/s00213-006-0431-2", "type": "journal-article", "created": {"date-parts": [[2006, 6, 16]], "date-time": "2006-06-16T08:09:20Z", "timestamp": 1150445360000}, "page": "321-330", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes"], "prefix": "10.1007", "volume": "187", "author": [{"given": "Angela N.", "family": "Duke", "sequence": "first", "affiliation": []}, {"given": "Donna M.", "family": "Platt", "sequence": "additional", "affiliation": []}, {"given": "James M.", "family": "Cook", "sequence": "additional", "affiliation": []}, {"given": "Shengming", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "Wenyuan", "family": "Yin", "sequence": "additional", "affiliation": []}, {"given": "Bruce A.", "family": "Mattingly", "sequence": "additional", "affiliation": []}, {"given": "James K.", "family": "Rowlett", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 6, 17]]}, "reference": [{"key": "431_CR1", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/S0376-8716(00)00122-8", "volume": "61", "author": "NA Ator", "year": "2000", "unstructured": "Ator NA, Weerts EM, Kaminski BJ, Kautz MA, Griffiths RR (2000) Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug Alcohol Depend 61:69\u201384", "journal-title": "Drug Alcohol Depend"}, {"key": "431_CR2", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0195-6663(80)80005-5", "volume": "1", "author": "SJ Cooper", "year": "1980", "unstructured": "Cooper SJ (1980) Benzodiazepines as appetite-enhancing compounds. Appetite 1:7\u201319", "journal-title": "Appetite"}, {"key": "431_CR3", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0014-2999(86)90466-8", "volume": "120", "author": "SJ Cooper", "year": "1986", "unstructured": "Cooper SJ (1986) Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam. Eur J Pharmacol 120:257\u2013265", "journal-title": "Eur J Pharmacol"}, {"key": "431_CR4", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1016/0149-7634(85)90028-4", "volume": "9", "author": "SJ Cooper", "year": "1985", "unstructured": "Cooper SJ, Estall LB (1985) Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors. Neurosci Biobehav Rev 9:5\u201319", "journal-title": "Neurosci Biobehav Rev"}, {"key": "431_CR5", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1016/0091-3057(85)90524-6", "volume": "22", "author": "SJ Cooper", "year": "1985", "unstructured": "Cooper SJ, Gilbert DB (1985) Clonazepam-induced hyperphagia in nondeprived rats: tests of pharmacological specificity with Ro5-4864, Ro5-3663, Ro15-1788 and CGS 9896. Pharmacol Biochem Behav 22:753\u2013760", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR6", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/0091-3057(85)90551-9", "volume": "23", "author": "SJ Cooper", "year": "1985", "unstructured": "Cooper SJ, Moores WR (1985) Benzodiazepine-induced hyperphagia in the nondeprived rat: comparisons with CL 218-872, zopiclone, tracazolate and phenobarbital. Pharmacol Biochem Behav 23:169\u2013172", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR7", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/0091-3057(94)90455-3", "volume": "49", "author": "MF Davies", "year": "1994", "unstructured": "Davies MF, Onaivi ES, Chen SW, Maguire PA, Tsai NF, Loew GH (1994) Evidence for central benzodiazepine receptor heterogeneity from behavior tests. Pharmacol Biochem Behav 49:47\u201356", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR8", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1006/appe.1998.0222", "volume": "32", "author": "SM Evans", "year": "1999", "unstructured": "Evans SM, Foltin RW, Fischman MW (1999) Food \u201ccravings\u201d and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite 32:331\u2013349", "journal-title": "Appetite"}, {"key": "431_CR9", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/0091-3057(85)90565-9", "volume": "23", "author": "RW Foltin", "year": "1985", "unstructured": "Foltin RW, Ellis S, Schuster CR (1985) Specific antagonism by RO 15-1788 of benzodiazepine-induced increases in food intake in rhesus monkeys. Pharmacol Biochem Behav 23:249\u2013252", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR10", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1007/BF00439545", "volume": "97", "author": "RW Foltin", "year": "1989", "unstructured": "Foltin RW, Fischman MW, Byrne MF (1989) Food intake in baboons: effects of diazepam. Psychopharmacology 97:443\u2013447", "journal-title": "Psychopharmacology"}, {"key": "431_CR11", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1080/10790268.1995.11719393", "volume": "18", "author": "JH Frisbie", "year": "1995", "unstructured": "Frisbie JH, Aguilera EJ (1995) Diazepam and body weight in myelopathy patients. J Spinal Cord Med 18:200\u2013202", "journal-title": "J Spinal Cord Med"}, {"key": "431_CR12", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1002/cne.903590111", "volume": "359", "author": "JM Fritschy", "year": "1995", "unstructured": "Fritschy JM, Mohler H (1995) GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154\u2013194", "journal-title": "J Comp Neurol"}, {"key": "431_CR13", "first-page": "1199", "volume": "260", "author": "RR Griffiths", "year": "1992", "unstructured": "Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199\u20131208", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR14", "first-page": "970", "volume": "43", "author": "KL Hadingham", "year": "1993", "unstructured": "Hadingham KL, Wingrove P, Le Bourdelles B, Palmer KJ, Ragan CI, Whiting PJ (1993) Cloning of cDNA sequences encoding human \u03b12 and \u03b13 \u03b3-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant \u03b11-, \u03b12-, \u03b13-, and \u03b15-containing human \u03b3-aminobutyric acidA receptors. Mol Pharmacol 43:970\u2013975", "journal-title": "Mol Pharmacol"}, {"key": "431_CR15", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1007/s002130050350", "volume": "132", "author": "M Haney", "year": "1997", "unstructured": "Haney M, Comer SD, Fischman MW, Foltin RW (1997) Alprazolam increases food intake in humans. Psychopharmacology 132:311\u2013314", "journal-title": "Psychopharmacology"}, {"key": "431_CR16", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1159/000155602", "volume": "21", "author": "S Hopf", "year": "1974", "unstructured": "Hopf S, Hartmann-Wiesner E, Kuhlmorgen B, Mayer S (1974) The behavioral repertoire of the squirrel monkey (Saimiri). Folia Primatol 21:225\u2013249", "journal-title": "Folia Primatol"}, {"key": "431_CR17", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1021/jm990341r", "volume": "43", "author": "Q Huang", "year": "2000", "unstructured": "Huang Q, He X, Ma C, Liu R, Yu S, Dayer CA, Wenger GR, McKernan R, Cook JM (2000) Pharmacophore/receptor models for GABAA/BzR subtypes (\u03b11\u03b23\u03b32, \u03b15\u03b23\u03b32, and \u03b16\u03b23\u03b32) via a comprehensive ligand-mapping approach. J Med Chem 43:71\u201395", "journal-title": "J Med Chem"}, {"key": "431_CR18", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1901/jeab.1963.6-249", "volume": "6", "author": "RT Kelleher", "year": "1963", "unstructured": "Kelleher RT, Gill CA, Riddle WC, Cook L (1963) On the use of the squirrel monkey in behavioral and pharmacological experiments. J Exp Anal Behav 6:249\u2013252", "journal-title": "J Exp Anal Behav"}, {"key": "431_CR19", "doi-asserted-by": "crossref", "first-page": "808", "DOI": "10.1016/0006-3223(92)90312-N", "volume": "31", "author": "TH Kelly", "year": "1992", "unstructured": "Kelly TH, Foltin RW, King L, Fischman MW (1992) Behavioral response to diazepam in a residential laboratory. Biol Psychiatry 31:808\u2013822", "journal-title": "Biol Psychiatry"}, {"key": "431_CR20", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1006/phrs.1998.0455", "volume": "39", "author": "R Kumar", "year": "1999", "unstructured": "Kumar R, Palit G, Singh JR, Dhawan BN (1999) Comparative behavioural effects of benzodiazepine and non-benzodiazepine anxiolytics in rhesus monkeys. Pharmacol Res 39:437\u2013444", "journal-title": "Pharmacol Res"}, {"key": "431_CR21", "doi-asserted-by": "crossref", "first-page": "1118", "DOI": "10.1124/jpet.104.081612", "volume": "313", "author": "SC Licata", "year": "2005", "unstructured": "Licata SC, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK (2005) Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther 313:1118\u20131125", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR22", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1007/s002139900354", "volume": "149", "author": "F Lobarinas", "year": "2000", "unstructured": "Lobarinas F, Falk JL (2000) Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Psychopharmacology 149:176\u2013180", "journal-title": "Psychopharmacology"}, {"key": "431_CR23", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1126/science.1115524", "volume": "310", "author": "S Luquet", "year": "2005", "unstructured": "Luquet S, Perez FA, Hnasko TS, Palmiter RD (2005) NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310:683\u2013685", "journal-title": "Science"}, {"key": "431_CR24", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0166-2236(96)80023-3", "volume": "19", "author": "RM McKernan", "year": "1996", "unstructured": "McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19:139\u2013143", "journal-title": "Trends Neurosci"}, {"key": "431_CR25", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.3109/00048679209072046", "volume": "26", "author": "DB Menkes", "year": "1992", "unstructured": "Menkes DB (1992) Triazolam-induced nocturnal bingeing with amnesia. Aust N Z J Psychiatry 26:320\u2013321", "journal-title": "Aust N Z J Psychiatry"}, {"key": "431_CR26", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1016/j.pbb.2004.09.004", "volume": "79", "author": "CP Mitchell", "year": "2004", "unstructured": "Mitchell CP, Ost ML, Flaherty CF (2004) Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm. Pharmacol Biochem Behav 79:523\u2013531", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR27", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1124/jpet.300.1.2", "volume": "300", "author": "H Mohler", "year": "2002", "unstructured": "Mohler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2\u20138", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR28", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/S1389-9457(02)00007-2", "volume": "3", "author": "TI Morgenthaler", "year": "2002", "unstructured": "Morgenthaler TI, Silber MH (2002) Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 3:323\u2013327", "journal-title": "Sleep Med"}, {"key": "431_CR29", "author": "JL Myers", "year": "2003", "edition": "2", "unstructured": "Myers JL, Well AD (2003) Research design and statistical analysis, 2nd edn. LEA, Mahwah, NJ", "volume-title": "Research design and statistical analysis", "DOI": "10.4324/9781410607034", "doi-asserted-by": "crossref"}, {"key": "431_CR30", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1016/0091-3057(95)00081-7", "volume": "51", "author": "T Naruse", "year": "1995", "unstructured": "Naruse T, Ishii R (1995) Relationship between histamine receptors in the brain and diazepam-induced hyperphagia in rats. Pharmacol Biochem Behav 51:923\u2013927", "journal-title": "Pharmacol Biochem Behav"}, {"key": "431_CR31", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1017/S1092852900009901", "volume": "10", "author": "DJ Nutt", "year": "2005", "unstructured": "Nutt DJ (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10:49\u201356", "journal-title": "CNS Spectr"}, {"key": "431_CR32", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1016/0014-2999(90)90375-G", "volume": "187", "author": "G Perrault", "year": "1990", "unstructured": "Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487\u2013494", "journal-title": "Eur J Pharmacol"}, {"key": "431_CR33", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/s00213-002-1189-9", "volume": "164", "author": "DM Platt", "year": "2002", "unstructured": "Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C (2002) Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/\u03b11-preferring antagonist \u03b2-CCt in squirrel monkeys. Psychopharmacology 164:151\u2013159", "journal-title": "Psychopharmacology"}, {"key": "431_CR34", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1124/jpet.104.080275", "volume": "313", "author": "DM Platt", "year": "2005", "unstructured": "Platt DM, Duggan A, Spealman RD, Cook JM, Li X, Yin W, Rowlett JK (2005) Contribution of the \u03b11GABAA and \u03b15GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther 313:658\u2013667", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR35", "doi-asserted-by": "crossref", "first-page": "1802", "DOI": "10.1111/j.1471-4159.1990.tb01237.x", "volume": "54", "author": "DB Pritchett", "year": "1990", "unstructured": "Pritchett DB, Seeburg PH (1990) Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 54:1802\u20131804", "journal-title": "J Neurochem"}, {"key": "431_CR36", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1038/338582a0", "volume": "3", "author": "DB Pritchett", "year": "1989", "unstructured": "Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, Seeburg PH (1989) Importance of novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 3:582\u2013585", "journal-title": "Nature"}, {"key": "431_CR37", "first-page": "162", "volume": "280", "author": "JK Rowlett", "year": "1997", "unstructured": "Rowlett JK, Woolverton WL (1997) Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats. J Pharmacol Exp Ther 280:162\u2013173", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR38", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/s00213-002-1275-z", "volume": "165", "author": "JK Rowlett", "year": "2003", "unstructured": "Rowlett JK, Spealman RD, Lelas S, Cook JM, Yin W (2003) Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors. Psychopharmacology 165:209\u2013215", "journal-title": "Psychopharmacology"}, {"key": "431_CR39", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1073/pnas.0405621102", "volume": "102", "author": "JK Rowlett", "year": "2005", "unstructured": "Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci USA 102:915\u2013920", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "431_CR40", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0014-2999(02)02191-X", "volume": "451", "author": "E Sanna", "year": "2002", "unstructured": "Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Giggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes. Eur J Pharmacol 451:103\u2013110", "journal-title": "Eur J Pharmacol"}, {"key": "431_CR41", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1016/0028-3908(88)90007-X", "volume": "27", "author": "DJ Sanger", "year": "1988", "unstructured": "Sanger DJ, Zivkovic B (1988) Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27:1125\u20131130", "journal-title": "Neuropharmacology"}, {"key": "431_CR42", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/0028-3908(92)90148-I", "volume": "31", "author": "DJ Sanger", "year": "1992", "unstructured": "Sanger DJ, Zivkovic B (1992) Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology 31:693\u2013700", "journal-title": "Neuropharmacology"}, {"key": "431_CR43", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1016/0031-9384(87)90359-3", "volume": "41", "author": "DJ Sanger", "year": "1987", "unstructured": "Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B (1987) The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure. Physiol Behav 41:235\u2013240", "journal-title": "Physiol Behav"}, {"key": "431_CR44", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1093/sleep/14.5.419", "volume": "14", "author": "CH Schenck", "year": "1991", "unstructured": "Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW (1991) Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 14:419\u2013431", "journal-title": "Sleep"}, {"key": "431_CR45", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.2174/1568026023393507", "volume": "2", "author": "W Sieghart", "year": "2002", "unstructured": "Sieghart W, Sperk G (2002) Subunit composition, distribution and function of GABAA receptor subtypes. Curr Top Med Chem 2:795\u2013816", "journal-title": "Curr Top Med Chem"}, {"key": "431_CR46", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/S0197-0186(99)00045-5", "volume": "34", "author": "W Sieghart", "year": "1999", "unstructured": "Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Hoger H, Adamiker D (1999) Structure and subunit composition of GABA(A) receptors. Neurochem Int 34:379\u2013385", "journal-title": "Neurochem Int"}, {"key": "431_CR47", "first-page": "488", "volume": "283", "author": "P Skolnick", "year": "1997", "unstructured": "Skolnick P, Hu RJ, Cook CM, Hurt SD, Trometer JD, Liu R, Huang Q, Cook JM (1997) [3H]RY 80: a high-affinity, selective ligand for \u03b3-aminobutyric acid A receptors containing alpha-5 subunits. J Pharmacol Exp Ther 283:488\u2013493", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR48", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1007/BF02245521", "volume": "111", "author": "KJ Stanhope", "year": "1993", "unstructured": "Stanhope KJ, Roe S, Dawson G, Draper F, Jackson A (1993) Effect of the benzodiazepine receptor agonist, zolpidem, on palatable fluid consumption in the rat. Psychopharmacology 111:185\u2013189", "journal-title": "Psychopharmacology"}, {"key": "431_CR49", "first-page": "41", "volume": "285", "author": "E Weerts", "year": "1998", "unstructured": "Weerts E, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41\u201353", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR50", "first-page": "522", "volume": "238", "author": "JG Wettstein", "year": "1986", "unstructured": "Wettstein JG, Spealman RD (1986) Behavioral effects of zopiclone, CL 218,872 and diazepam in squirrel monkeys: antagonism by Ro 15-1788 and CGS 8216. J Pharmacol Exp Ther 238:522\u2013528", "journal-title": "J Pharmacol Exp Ther"}, {"key": "431_CR51", "doi-asserted-by": "crossref", "first-page": "930", "DOI": "10.1037/h0036404", "volume": "86", "author": "RA Wise", "year": "1974", "unstructured": "Wise RA, Dawson V (1974) Diazepam-induced eating and lever pressing for food in sated rats. J Comp Physiol Psychol 86:930\u2013941", "journal-title": "J Comp Physiol Psychol"}, {"key": "431_CR52", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1016/0091-3057(89)90504-2", "volume": "33", "author": "RE Yerbury", "year": "1989", "unstructured": "Yerbury RE, Cooper SJ (1989) Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867S, or Ro23-0364, in the rat. Pharmacol Biochem Behav 33:303\u2013307", "journal-title": "Pharmacol Biochem Behav"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-006-0431-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-006-0431-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-006-0431-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T16:31:24Z", "timestamp": 1558629084000}, "score": 77.89311, "issued": {"date-parts": [[2006, 6, 17]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2006, 8]]}, "issue": "3"}, "alternative-id": ["431"], "URL": "http://dx.doi.org/10.1007/s00213-006-0431-2", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T03:25:26Z", "timestamp": 1574825126875}, "reference-count": 46, "publisher": "Cambridge University Press (CUP)", "issue": "1", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2014, 11, 7]], "date-time": "2014-11-07T00:00:00Z", "timestamp": 1415318400000}, "delay-in-days": 3597, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CNS spectr."], "published-print": {"date-parts": [[2005, 1]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>Benzodiazepines (BZs) are clinically used as anxiolytic, hypnotic, anticonvulsant, and antispasmodic drugs. Research using transgenic mouse models has suggested that the effects of BZs involve multiple subtypes of the \u03b3-aminobutyric acid type A (GABA<jats:sub>A</jats:sub>) receptor, identified by specific \u03b1 subunits (\u03b1<jats:sub>1</jats:sub>, \u03b1<jats:sub>2</jats:sub>, \u03b1<jats:sub>3</jats:sub>, \u03b1<jats:sub>5</jats:sub>). This review discusses the experimental uses of \u03b2-carboline-3-carboxylate-t-butyl ester (\u03b2CCT), a drug that binds preferentially to the GABA<jats:sub>A</jats:sub> \u03b11 subtype but exerts no action (ie, is a pharmacologic antagonist at the GABA<jats:sub>A</jats:sub> \u03b11 subtype receptor). \u03b2CCT blocks the anxiolytic-like effects of BZs, although studies in primates suggests this antagonism may reflect multiple receptor populations. \u03b2CCT antagonized the ataxic but not muscle relaxant effects of BZs, a finding that implicates the GABA<jats:sub>A</jats:sub> \u03b1<jats:sub>1</jats:sub> subtype receptor in ataxia but not muscle relaxation. The potential clinical utility of \u03b2CCT is discussed, both in terms of treatment (ie, hepatic encephalopathy) and as a diagnostic imaging agent. Altogether, these results indicate that subtype-selective antagonists represent a useful approach to studying receptor mechanisms underlying the behavioral effects of BZ-type drugs.</jats:p>", "DOI": "10.1017/s1092852900009895", "type": "journal-article", "created": {"date-parts": [[2016, 8, 2]], "date-time": "2016-08-02T04:41:59Z", "timestamp": 1470112919000}, "page": "40-48", "source": "Crossref", "is-referenced-by-count": 27, "title": ["Selective Antagonism of GABAA Receptor Subtypes: An In Vivo Approach to Exploring the Therapeutic and Side Effects of Benzodiazepine\u2013Type Drugs"], "prefix": "10.1017", "volume": "10", "author": [{"given": "James K.", "family": "Rowlett", "sequence": "first", "affiliation": []}, {"given": "James M.", "family": "Cook", "sequence": "additional", "affiliation": []}, {"given": "Angela N.", "family": "Duke", "sequence": "additional", "affiliation": []}, {"given": "Donna M.", "family": "Platt", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2014, 11, 7]]}, "reference": [{"key": "S1092852900009895_ref020", "DOI": "10.1016/0014-5793(91)81076-K", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref028", "DOI": "10.1016/0091-3057(79)90304-6", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref007", "DOI": "10.1016/S0166-2236(96)80023-3", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref035", "DOI": "10.1007/s002130100754", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref001", "DOI": "10.1007/s002130050422", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref010", "DOI": "10.2174/1568007033482841", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref027", "first-page": "12A", "article-title": "The role of the GABAA \u03b11 subunit in mediating the sedative and anxiolytic properties of benzodiazepines", "volume": "25", "author": "Carroll", "year": "1991", "journal-title": "Alcoholism Clin Exp Res"}, {"key": "S1092852900009895_ref014", "DOI": "10.1016/0024-3205(84)90464-8", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref002", "DOI": "10.1016/S0163-7258(00)00083-8", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref038", "DOI": "10.1046/j.1365-2125.2002.t01-10-01714.x", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref039", "first-page": "641", "article-title": "Flumazenil: a benzodiazepine antagonist", "volume": "12", "author": "Hoffman", "year": "1993", "journal-title": "Clin Pharm"}, {"key": "S1092852900009895_ref036", "first-page": "1246", "article-title": "Zolpidem and triazolam in humans: behavioral and subjective effects and abuse reliability", "volume": "255", "author": "Evans", "year": "1990", "journal-title": "J Pharmacol Exp Ther"}, {"key": "S1092852900009895_ref033", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1124/mol.59.3.442", "article-title": "Molecular targets for the myorelaxant action of diazepam", "volume": "59", "author": "Crestani", "year": "2001", "journal-title": "Mol Pharmacol"}, {"key": "S1092852900009895_ref030", "DOI": "10.1038/44579", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref016", "first-page": "710", "article-title": "BZ1 receptor subtype specific ligands. Synthesis and biological properties of ~CCt, a BZ1 receptor subtype specific antagonist", "volume": "5", "author": "Cox", "year": "1995", "journal-title": "Med Chem Res"}, {"key": "S1092852900009895_ref006", "DOI": "10.1016/S0028-3908(02)00199-5", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref019", "DOI": "10.1016/S0893-133X(98)00052-9", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref026", "DOI": "10.1007/s00213-002-1275-z", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref042", "DOI": "10.1016/S0924-977X(02)00105-0", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref012", "first-page": "753", "article-title": "SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors", "volume": "298", "author": "Griebel", "year": "2001", "journal-title": "J Pharmacol Exp Ther"}, {"key": "S1092852900009895_ref018", "DOI": "10.1007/s002130051108", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref005", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.1093/ajhp/59.11.1067", "article-title": "Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate", "volume": "59", "author": "Smith", "year": "2002", "journal-title": "Am J Health Syst Pharm"}, {"key": "S1092852900009895_ref004", "year": "2001", "volume-title": "Prescription Drugs: Abuse and Addiction"}, {"key": "S1092852900009895_ref011", "DOI": "10.1038/75761", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref034", "first-page": "1114", "article-title": "Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies", "volume": "261", "author": "Facklam", "year": "1992", "journal-title": "J Pharmacol Exp Ther"}, {"key": "S1092852900009895_ref017", "DOI": "10.1021/jm990341r", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref022", "doi-asserted-by": "crossref", "first-page": "2124", "DOI": "10.1038/sj.npp.1300239", "article-title": "The reinforcing properties of alcohol are mediated by GABA(Al) receptors in the ventral pallidum", "volume": "28", "author": "June", "year": "2003", "journal-title": "Neuropsychopharmacology"}, {"key": "S1092852900009895_ref032", "DOI": "10.1111/j.1527-3458.2003.tb00241.x", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref025", "DOI": "10.1007/s00213-002-1189-9", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref037", "DOI": "10.1016/S0893-133X(02)00310-X", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref009", "DOI": "10.1016/S0165-6147(00)01646-1", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref008", "first-page": "648", "article-title": "The GABAA receptor gene family: new opportunities for drug development", "volume": "6", "author": "Whiting", "year": "2003", "journal-title": "Curr Opin Drag Discov Devel"}, {"key": "S1092852900009895_ref021", "DOI": "10.1002/cne.903590111", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref024", "DOI": "10.1097/00008877-200004000-00004", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref031", "DOI": "10.1126/science.290.5489.131", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref029", "first-page": "247", "article-title": "Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-buty1 ester (beta-CCt)", "volume": "297", "author": "Rowlett", "year": "2001", "journal-title": "J Pharmacol Exp Ther"}, {"key": "S1092852900009895_ref003", "DOI": "10.1124/jpet.300.1.2", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref045", "DOI": "10.1016/S0969-8051(03)00006-4", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref023", "DOI": "10.1038/sj.bjp.0703717", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref013", "DOI": "10.1021/jm0202019", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref046", "DOI": "10.1097/00004647-200207000-00013", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref040", "DOI": "10.1046/j.1365-2036.2002.01191.x", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref044", "DOI": "10.1093/brain/awg138", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref015", "first-page": "55", "article-title": "Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: bind affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis", "volume": "16", "author": "Huang", "year": "1999", "journal-title": "Drug Des Discov"}, {"key": "S1092852900009895_ref041", "DOI": "10.1182/blood-2003-03-0739", "doi-asserted-by": "publisher"}, {"key": "S1092852900009895_ref043", "DOI": "10.1007/s00259-002-1083-z", "doi-asserted-by": "publisher"}], "container-title": ["CNS Spectrums"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1092852900009895", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 6]], "date-time": "2019-05-06T19:20:20Z", "timestamp": 1557170420000}, "score": 37.48886, "issued": {"date-parts": [[2005, 1]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[2005, 1]]}, "issue": "1"}, "alternative-id": ["S1092852900009895"], "URL": "http://dx.doi.org/10.1017/s1092852900009895", "relation": {"cites": []}, "ISSN": ["1092-8529", "2165-6509"], "issn-type": [{"value": "1092-8529", "type": "print"}, {"value": "2165-6509", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T09:58:27Z", "timestamp": 1574330307975}, "publisher-location": "Totowa, NJ", "reference-count": 75, "publisher": "Humana Press", "isbn-type": [{"value": "9781588298133", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59745-465-0_7", "type": "book-chapter", "created": {"date-parts": [[2007, 11, 16]], "date-time": "2007-11-16T04:40:39Z", "timestamp": 1195188039000}, "page": "143-168", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Abuse and Dependence Liability of GABAA-Receptor Modulators"], "prefix": "10.1007", "author": [{"given": "James K.", "family": "Rowlett", "sequence": "first", "affiliation": []}, {"given": "Angela N.", "family": "Duke", "sequence": "additional", "affiliation": []}, {"given": "Donna M.", "family": "Platt", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "7_CR1", "doi-asserted-by": "publisher", "first-page": "3826", "DOI": "10.1073/pnas.070042397", "volume": "97", "author": "K. M. H\u00f6ld", "year": "2000", "unstructured": "H\u00f6ld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., and Casida, J. E. (2000) \u03b1-Thujone (the active component of absinthe): \u03b3-Aminobutyric acid type A receptor modulation and metabolic detoxification. Proc. Natl. Acad. Sci. USA 97, 3826\u20133831.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "7_CR2", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1016/j.pharmthera.2003.12.001", "volume": "101", "author": "S. Kumar", "year": "2004", "unstructured": "Kumar, S., Fleming, R. L., and Morrow, A. L. (2004) Ethanol regulation of \u03b3-aminobutyric acidA receptors: genomic and nongenomic mechanisms. Pharmacol. Ther. 101, 211\u2013226.", "journal-title": "Pharmacol. Ther."}, {"key": "7_CR3", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1016/0091-3057(87)90588-0", "volume": "27", "author": "N. A. Ator", "year": "1987", "unstructured": "Ator, N. A. and Griffiths, R. R. (1987) Self-administration of barbiturates and benzodiazepines: A review. Pharmacol. Biochem. Behav. 27, 391\u2013398.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "7_CR4", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1177/070674370505000702", "volume": "50", "author": "A. Tone", "year": "2005", "unstructured": "Tone, A. (2005) Listening to the past: history, psychiatry, and anxiety. Can. J. Psychiatry 50, 373\u2013380.", "journal-title": "Can. J. Psychiatry"}, {"key": "7_CR5", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1007/BF02245824", "volume": "118", "author": "J. H. Woods", "year": "1995", "unstructured": "Woods, J. H. and Winger, G. (1995) Current benzodiazepine issues. Psychopharmacology 118, 107\u2013115.", "journal-title": "Psychopharmacology"}, {"key": "7_CR6", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1017/S1092852900009901", "volume": "10", "author": "D. J. Nutt", "year": "2005", "unstructured": "Nutt, D. J. (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 10, 49\u201356.", "journal-title": "CNS Spectr"}, {"key": "7_CR7", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1007/BF02245825", "volume": "118", "author": "R. R. Griffiths", "year": "1995", "unstructured": "Griffiths, R. R. (1995) Commentary on review by Woods and Winger. Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial. Psychopharmacology 118, 116\u2013117.", "journal-title": "Psychopharmacology"}, {"key": "7_CR8", "doi-asserted-by": "publisher", "first-page": "1389", "DOI": "10.1126/science.2551039", "volume": "245", "author": "D. B. Pritchett", "year": "1989", "unstructured": "Pritchett, D. B., L\u00fcddens, H., and Seeburg, P. H. (1989) Type I and type II GABAA benzodiazepine receptor produced in transfected cells. Science 245, 1389\u20131392.", "journal-title": "Science"}, {"key": "7_CR9", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1126/science.290.5489.131", "volume": "290", "author": "K. L\u00f6w", "year": "2000", "unstructured": "L\u00f6w, K., Crestani, F., Keist, R., et al. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131\u2013134.", "journal-title": "Science"}, {"key": "7_CR10", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1038/75761", "volume": "3", "author": "R. M. McKernan", "year": "2000", "unstructured": "McKernan, R. M., Rosahl, T. W., Reynolds, D. S., et al. (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor alpha1 subtype. Nature Neurosci. 3, 587\u2013592.", "journal-title": "Nature Neurosci"}, {"key": "7_CR11", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1016/S0165-6147(00)01646-1", "volume": "22", "author": "U. Rudolph", "year": "2000", "unstructured": "Rudolph, U., Crestani, F., and M\u00f6hler, H. (2000) GABAA receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22, 188\u2013194.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "7_CR12", "doi-asserted-by": "publisher", "first-page": "915", "DOI": "10.1073/pnas.0405621102", "volume": "102", "author": "J. K. Rowlett", "year": "2005", "unstructured": "Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R., and Dawson, G. R. (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc. Natl. Acad. Sci. USA 102, 915\u2013920.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "7_CR13", "first-page": "139", "volume": "19", "author": "R. M. McKernan", "year": "1996", "unstructured": "McKernan, R. M. and Whiting, P. J. (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Pharmacol. Sci. 19, 139\u2013143.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "7_CR14", "doi-asserted-by": "crossref", "first-page": "5572", "DOI": "10.1523/JNEUROSCI.22-13-05572.2002", "volume": "22", "author": "N. Collinson", "year": "2002", "unstructured": "Collinson, N., Kuenzi, F. M., Jarolimek, W., et al. (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the \u03b15 subunit of the GABAA receptor J. Neurosci. 22, 5572\u20135580.", "journal-title": "J. Neurosci."}, {"key": "7_CR15", "doi-asserted-by": "publisher", "first-page": "8980", "DOI": "10.1073/pnas.142288699", "volume": "99", "author": "F. Crestani", "year": "2002", "unstructured": "Crestani, F., Keist, R., Fritschy, J. M., et al. (2002) Trace fear conditioning involves hippocampal \u03b15 GABAA receptors. Proc. Natl. Acad. Sci. USA 99, 8980\u20138985.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "7_CR16", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1093/jhmas/52.3.338", "volume": "52", "author": "S. Speaker", "year": "1997", "unstructured": "Speaker, S. (1997) From \u201chappiness pills\u201d to \u201cnational nightmare\u201d: changing cultural assessment of minor tranquilizers in America, 1955\u20131980. J. Hist. Med. Allied Sci. 52, 338\u2013376.", "journal-title": "J. Hist. Med. Allied Sci."}, {"key": "7_CR17", "author": "B. Gordon", "year": "1979", "unstructured": "Gordon, B. (1979) I\u2019m Dancing as Fast as I Can. Harper & Row, New York, NY.", "volume-title": "I\u2019m Dancing as Fast as I Can"}, {"key": "7_CR18", "author": "US Committee on Labor and Human Resources", "year": "1979", "unstructured": "US Committee on Labor and Human Resources (1979) Use and misuse of benzodiazepines. Washington DC, US. Government Printing Office.", "volume-title": "Use and misuse of benzodiazepines"}, {"key": "7_CR19", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1017/S1092852900009883", "volume": "10", "author": "N. A. Ator", "year": "2005", "unstructured": "Ator, N. A. (2005) Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectr. 10, 31\u201339.", "journal-title": "CNS Spectr"}, {"key": "7_CR20", "first-page": "251", "volume": "39", "author": "J. H. Woods", "year": "1987", "unstructured": "Woods, J. H., Katz, J. L., and Winger, G. (1987) Benzodiazepines: Use, abuse, and consequences. Pharmacol. Rev. 39, 251\u2013419.", "journal-title": "Pharmacol. Rev."}, {"key": "7_CR21", "first-page": "151", "volume": "44", "author": "J. H. Woods", "year": "1992", "unstructured": "Woods, J. H., Katz, J. L., and Winger, G. (1992) Benzodiazepines: Use, abuse, and consequences. Pharmacol. Rev. 44, 151\u2013347.", "journal-title": "Pharmacol. Rev."}, {"key": "7_CR22", "first-page": "4", "volume": "66", "author": "J. F. Rosenbaum", "year": "2005", "unstructured": "Rosenbaum, J. F. (2005) Attitudes toward benzodiazepines over the years. J. Clin. Psychiatry 66, 4\u20138.", "journal-title": "J. Clin. Psychiatry"}, {"key": "7_CR23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/s002130050422", "volume": "134", "author": "R. R. Griffiths", "year": "1997", "unstructured": "Griffiths, R. R. and Weerts, E. M. (1997) Benzodiazepine self-administration in humans and laboratory animals \u2014 implications for problems of long-term use and abuse. Psychopharmacology 134, 1\u201337.", "journal-title": "Psychopharmacology"}, {"key": "7_CR24", "first-page": "31", "volume": "66", "author": "R. R. Griffiths", "year": "2005", "unstructured": "Griffiths, R. R. and Johnson, M. W. (2005) Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. J. Clin. Psychiatry 66, 31\u201341.", "journal-title": "J. Clin. Psychiatry"}, {"key": "7_CR25", "unstructured": "Crane, E. H. and Nemanski, N. (2004) Benzodiazepines in drug abuse-related emergency department visits: 1995\u20132002. The DAWN Report, April 2004, Office of Applied Studies, US Substance Abuse and Mental Health Services Administration (available online at http://dawninfo.samhsa.gov/). Last accessed: January 3, 2007."}, {"key": "7_CR26", "unstructured": "Crane, E. H. and Nemanski, N. (2004) Demographic characteristics of benzodiazepine-involved ED visits. The DAWN Report, July 2004, Office of Applied Studies, US Substance Abuse and Mental Health Services Administration (available online at http://dawninfo.samhsa.gov/). Last accessed: January 3, 2007."}, {"key": "7_CR27", "unstructured": "The DASIS Report (2005) Characteristics of primary tranquilizer admissions: 2002. Drug and Alcohol Services Information System, Office of Applied Studies, Substance Abuse and Mental Health Services Administration (available online at http://www.oas.samhsa.gov ). Last accessed: January 3, 2007."}, {"key": "7_CR28", "doi-asserted-by": "crossref", "first-page": "1501", "DOI": "10.1176/ajp.145.12.1501", "volume": "145", "author": "D. A. Ciraulo", "year": "1988", "unstructured": "Ciraulo, D. A., Sands, B. F., and Shader, R. I. (1988) Critical review of liability for benzodiazepine abuse among alcoholics. Am. J. Psychiatry 145, 1501\u20131506.", "journal-title": "Am. J. Psychiatry"}, {"key": "7_CR29", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1007/BF02245577", "volume": "115", "author": "H. Wit de", "year": "1993", "unstructured": "de Wit, H. and Doty, P. (1993) Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study. Psychopharmacology 115, 529\u2013538.", "journal-title": "Psychopharmacology"}, {"key": "7_CR30", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1007/BF02246172", "volume": "123", "author": "S. M. Evans", "year": "1996", "unstructured": "Evans, S. M., Griffiths, R. R., and de Wit, H. (1996) Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology 123, 154\u2013163.", "journal-title": "Psychopharmacology"}, {"key": "7_CR31", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1177/106002808301700708", "volume": "17", "author": "K. G. Sobel", "year": "1983", "unstructured": "Sobel, K. G. and McCart, G. M. (1983) Drug use and accidental falls in an intermediate care facility. Drug Intell. Clin. Pharm. 17, 539\u2013542.", "journal-title": "Drug Intell. Clin. Pharm."}, {"key": "7_CR32", "doi-asserted-by": "publisher", "first-page": "1801", "DOI": "10.1001/archinte.155.16.1801", "volume": "155", "author": "R. M. Herings", "year": "1995", "unstructured": "Herings, R. M., Stricker, B. H., de Boer, A., Bakker, A., and Sturmans, F. (1995) Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch. Intern. Med. 155, 1801\u20131807.", "journal-title": "Arch. Intern. Med."}, {"key": "7_CR33", "doi-asserted-by": "publisher", "first-page": "S55", "DOI": "10.1016/S0376-8716(03)00099-1", "volume": "70", "author": "N. A. Ator", "year": "2003", "unstructured": "Ator, N. A. and Griffiths, R. R. (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend. 70, S55\u2013S72.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR34", "doi-asserted-by": "publisher", "first-page": "S41", "DOI": "10.1016/S0376-8716(03)00098-X", "volume": "70", "author": "R. R. Griffiths", "year": "2003", "unstructured": "Griffiths, R. R., Bigelow, G. E., and Ator, N. A. (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend. 70, S41\u2013S54.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR35", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1037/1064-1297.8.3.294", "volume": "8", "author": "S. Lelas", "year": "2000", "unstructured": "Lelas, S., Spealman, R. D., and Rowlett, J. K. (2000) Using behavior to elucidate receptor mechanisms: A review of the discriminative stimulus effects of benzodiazepines. Exp. Clin. Psychopharmacol. 8, 294\u2013311.", "journal-title": "Exp. Clin. Psychopharmacol."}, {"key": "7_CR36", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1037/1064-1297.13.4.348", "volume": "13", "author": "T. C. Helmus", "year": "2005", "unstructured": "Helmus, T. C., Tancer, M., and Johanson, C. E. (2005) Reinforcing effects of diazepam under anxiogenic conditions in individuals with social anxiety. Exp. Clin. Psychopharmacol. 13, 348\u2013356.", "journal-title": "Exp. Clin. Psychopharmacol."}, {"key": "7_CR37", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1016/0376-8716(93)90090-D", "volume": "32", "author": "M. Y. Iguchi", "year": "1993", "unstructured": "Iguchi, M. Y., Handelsman, L., Bickel, W. K., and Griffiths, R. R. (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend. 32, 257\u2013266.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR38", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.5694/j.1326-5377.1995.tb126051.x", "volume": "162", "author": "S. G. Darke", "year": "1995", "unstructured": "Darke, S. G., Ross, J. E., and Hall, W. D. (1995) Benzodiazepine use among injecting heroin users. Med. J. Aust. 162, 645\u2013647.", "journal-title": "Med. J. Aust."}, {"key": "7_CR39", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1111/j.1360-0443.1987.tb01508.x", "volume": "82", "author": "K. M. Perera", "year": "1987", "unstructured": "Perera, K. M., Tulley, M., and Jenner, F. A. (1987) The use of benzodiazepines among drug addicts. Br. J. Addict. 82, 511\u2013515.", "journal-title": "Br. J. Addict."}, {"key": "7_CR40", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1016/S0376-8716(98)00175-6", "volume": "55", "author": "M. Gelkopf", "year": "1999", "unstructured": "Gelkopf, M., Bleich, A., Hayward, R., Bodner, G., and Adelson, M. (1999) Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend. 55, 63\u201368.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR41", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1007/BF00431693", "volume": "86", "author": "J. Bergman", "year": "1985", "unstructured": "Bergman, J. and Johanson, C. E. (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology 86, 108\u2013113.", "journal-title": "Psychopharmacology"}, {"key": "7_CR42", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1007/BF02244196", "volume": "103", "author": "R. R. Griffiths", "year": "1991", "unstructured": "Griffiths, R. R., Lamb, R. J., Sannerud, C. A., Ator, N. A., and Brady, J. V. (1991) Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons. Psychopharmacology 103, 154\u2013161.", "journal-title": "Psychopharmacology"}, {"key": "7_CR43", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1007/s00213-004-1986-4", "volume": "178", "author": "J. H. Broadbear", "year": "2005", "unstructured": "Broadbear, J. H., Winger, G., and Woods, J. H. (2005) Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology 178, 83\u201391.", "journal-title": "Psychopharmacology"}, {"key": "7_CR44", "first-page": "505", "volume": "195", "author": "G. Winger", "year": "1975", "unstructured": "Winger, G., Stitzer, M. L., and Woods, J. H. (1975) Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. J. Pharmacol. Exp. Ther. 195, 505\u2013514.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR45", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1037/1064-1297.10.4.367", "volume": "10", "author": "J. K. Rowlett", "year": "2002", "unstructured": "Rowlett, J. K., Rodefer, J. S., and Spealman, R. D. (2002) Self-administration of cocaine, alfentanil, and nalbuphine under progressive-ratio schedules: Consumer demand and labor supply analysis of relative reinforcing effectiveness. Exp. Clin. Psychopharmacol. 10, 367\u2013375.", "journal-title": "Exp. Clin. Psychopharmacol."}, {"key": "7_CR46", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1007/s002130050487", "volume": "135", "author": "E. M. Weerts", "year": "1998", "unstructured": "Weerts, E. M., Kaminski, B. J., and Griffiths, R. R. (1998) Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Psychopharmacology 135, 70\u201381.", "journal-title": "Psychopharmacology"}, {"key": "7_CR47", "first-page": "1199", "volume": "260", "author": "R. R. Griffiths", "year": "1992", "unstructured": "Griffiths, R. R., Sannerud, C. A., Ator, N. A., and Brady, J. V. (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J. Pharmacol. Exp. Ther. 260, 1199\u20131208.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR48", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1016/S0376-8716(00)00123-X", "volume": "24", "author": "N. A. Ator", "year": "2000", "unstructured": "Ator, N. A. (2000) Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons. Drug Alcohol Depend. 24, 55\u201368.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR49", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1124/jpet.105.089920", "volume": "316", "author": "J. R. Atack", "year": "2006", "unstructured": "Atack, J. R., Wafford, K. A., Tye, S. J., et al. (2006) TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-30ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b] pyridazine], an agonist selective for \u03b12 and \u03b13-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. J. Pharmacol. Exp. Ther. 316, 410\u2013422.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR50", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1017/S1092852900009871", "volume": "10", "author": "G. R. Dawson", "year": "2005", "unstructured": "Dawson, G. R., Collinson, N., and Atack, J. R. (2005) Development of subtype selective GABAA modulators. CNS Spectr. 10, 21\u201327.", "journal-title": "CNS Spectr"}, {"key": "7_CR51", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1016/0740-5472(91)90023-4", "volume": "8", "author": "H. Ashton", "year": "1991", "unstructured": "Ashton, H. (1991) Protracted withdrawal syndromes from benzodiazepines. J. Subst. Abuse Treat. 8, 19\u201328.", "journal-title": "J. Subst. Abuse Treat."}, {"key": "7_CR52", "doi-asserted-by": "publisher", "first-page": "1455", "DOI": "10.1111/j.1360-0443.1994.tb03743.x", "volume": "89", "author": "H. Petursson", "year": "1994", "unstructured": "Petursson, H. (1994) The benzodiazepine withdrawal syndrome. Addiction. 89, 1455\u20131459.", "journal-title": "Addiction"}, {"key": "7_CR53", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1007/s00213-004-2009-1", "volume": "178", "author": "M. Z. Mintzer", "year": "2005", "unstructured": "Mintzer, M. Z. and Griffiths, R. R. (2005) Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. Psychopharmacology 178, 259\u2013267.", "journal-title": "Psychopharmacology"}, {"key": "7_CR54", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.4088/JCP.v66n0104", "volume": "66", "author": "C. P. O\u2019Brien", "year": "2005", "unstructured": "O\u2019Brien, C. P. (2005) Benzodiazepine use, abuse, and dependence. J. Clin. Psychiatry 66, 28\u201333.", "journal-title": "J. Clin. Psychiatry"}, {"key": "7_CR55", "first-page": "45", "volume": "6", "author": "A. Orsini", "year": "1990", "unstructured": "Orsini, A., Brancato, V., and Smeraldi, E. (1990) Length of anxiolytic treatment and benzodiazepine withdrawal symptoms: a double blind study with clotiazepam. New Trends Exp. Clin. Psychiatry 6, 45\u201352.", "journal-title": "New Trends Exp. Clin. Psychiatry"}, {"key": "7_CR56", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1007/s002130051161", "volume": "147", "author": "M. Z. Mintzer", "year": "1999", "unstructured": "Mintzer, M. Z., Stoller, K. B., and Griffiths, R. R. (1999) A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology 147, 200\u2013209.", "journal-title": "Psychopharmacology"}, {"key": "7_CR57", "doi-asserted-by": "publisher", "first-page": "487", "DOI": "10.1016/j.sleep.2005.06.004", "volume": "6", "author": "T. Roth", "year": "2005", "unstructured": "Roth, T., Walsh, J. K., Krystal, A., Wessel, T., and Roehrs, T. A. (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med. 6, 487\u2013495.", "journal-title": "Sleep Med"}, {"key": "7_CR58", "doi-asserted-by": "publisher", "first-page": "939", "DOI": "10.1016/S0091-3057(97)00503-0", "volume": "59", "author": "J. R. Martin", "year": "1998", "unstructured": "Martin, J. R., Moreau, J. L., Jenck, F., and Pieri, L. (1998) Sarmazenil-precipitated withdrawal: A reliable method for assessing dependence liability of benzodiazepine receptor ligands. Pharmacol. Biochem. Behav. 59, 939\u2013944.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "7_CR59", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1097/01.fbp.0000082131.08343.0e", "volume": "14", "author": "B. J. Kaminski", "year": "2003", "unstructured": "Kaminski, B. J., Sannerud, C. A., Weerts, E. M., Lamb, R. J., and Griffiths, R. R. (2003) Physical dependence in baboons chronically treated with low and high doses of diazepam. Behav. Pharmacol. 14, 331\u2013342.", "journal-title": "Behav. Pharmacol."}, {"key": "7_CR60", "doi-asserted-by": "publisher", "first-page": "1378", "DOI": "10.1124/jpet.105.094474", "volume": "316", "author": "N. R. Mirza", "year": "2006", "unstructured": "Mirza, N. R. and Nielsen, E. \u00d8. (2006) Do subtype-selective GABAA receptor modulators have a reduced propensity to induce physical dependence in mice? J. Pharmacol. Exp. Ther. 316, 1378\u20131385.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR61", "first-page": "41", "volume": "285", "author": "E. M. Weerts", "year": "1998", "unstructured": "Weerts, E. M., Ator, N. A., Grech, D. M., and Griffiths, R. R. (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J. Pharmacol. Exp. Ther. 285, 41\u201353.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR62", "first-page": "1227", "volume": "298", "author": "L. R. McMahon", "year": "2001", "unstructured": "McMahon, L. R., Gerak, L. R., and France, C. P. (2001) Potency of positive \u03b3-aminobutyric acidA modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. J. Pharmacol. Exp. Ther. 298, 1227\u20131235.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR63", "doi-asserted-by": "publisher", "first-page": "1161", "DOI": "10.1126/science.6287579", "volume": "217", "author": "S. E. Lukas", "year": "1982", "unstructured": "Lukas, S. E. and Griffiths R. R. (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 217, 1161\u20131163.", "journal-title": "Science"}, {"key": "7_CR64", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/0014-2999(85)90050-0", "volume": "107", "author": "S. J. Grant", "year": "1985", "unstructured": "Grant, S. J., Galloway, M. P., Mayor, R., et al. (1985) Precipitated diazepam withdrawal elevates noradrenergic metabolism in primate brain. Eur. J. Pharmacol. 107, 127\u2013132.", "journal-title": "Eur. J. Pharmacol."}, {"key": "7_CR65", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/0014-2999(86)90005-1", "volume": "132", "author": "D. W. Gallager", "year": "1986", "unstructured": "Gallager, D. W., Heninger, K., and Heninger, G. (1986) Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. Eur. J. Pharmacol. 132, 31\u201338.", "journal-title": "Eur. J. Pharmacol."}, {"key": "7_CR66", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/0014-2999(84)90218-8", "volume": "100", "author": "S. E. Lukas", "year": "1984", "unstructured": "Lukas, S. E. and Griffiths, R. R. (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur. J. Pharmacol. 100, 163\u2013171.", "journal-title": "Eur. J. Pharmacol."}, {"key": "7_CR67", "first-page": "1152", "volume": "265", "author": "J. W. Sloan", "year": "1993", "unstructured": "Sloan, J. W., Martin, W. R., and Wala, E. (1993) Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog. J. Pharmacol. Exp. Ther. 265, 1152\u20131162.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR68", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1016/S0163-7258(03)00029-9", "volume": "98", "author": "C. Allison", "year": "2003", "unstructured": "Allison, C. and Pratt, J. A. (2003) Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol. Ther. 98, 171\u2013195.", "journal-title": "Pharmacol. Ther."}, {"key": "7_CR69", "first-page": "298", "volume": "263", "author": "G. Perrault", "year": "1992", "unstructured": "Perrault, G., Morel, E., Sanger, D. J., and Zivkovic, B. (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J. Pharmacol. Exp. Ther. 263, 298\u2013303.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "7_CR70", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1016/S0091-3057(00)00176-3", "volume": "66", "author": "E. E. Elliot", "year": "2000", "unstructured": "Elliot, E. E. and White, J. M. (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol. Biochem. Behav. 66, 361\u2013369.", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "7_CR71", "first-page": "285", "volume": "9", "author": "E. M. Weerts", "year": "1998", "unstructured": "Weerts, E. M. and Griffiths, R. R. (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav. Pharmacol. 9, 285\u2013297.", "journal-title": "Behav. Pharmacol."}, {"key": "7_CR72", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/S0376-8716(00)00122-8", "volume": "61", "author": "N. A. Ator", "year": "2000", "unstructured": "Ator, N. A., Weerts, E. M., Kaminski, B. J., Kautz, M. A., and Griffiths, R. R. (2000) Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Drug Alcohol Depend. 61, 69\u201384.", "journal-title": "Drug Alcohol Depend"}, {"key": "7_CR73", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1016/0893-133X(94)00074-A", "volume": "12", "author": "D. S. Cowley", "year": "1995", "unstructured": "Cowley, D. S., Roy-Byrne, P. P., Radant, A., et al. (1995) Benzodiazepine sensitivity in panic disorder: Effects of chronic alprazolam treatment. Neuropsychopharmacology 12, 147\u2013157.", "journal-title": "Neuropsychopharmacology"}, {"key": "7_CR74", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1081/ADA-120020513", "volume": "29", "author": "W. W. Stoops", "year": "2003", "unstructured": "Stoops, W. W. and Rush, C. R. (2003) Differential effects in humans after repeated asministratios of zolpidem and triazlolam. Am. J. Drug Alcohol Abuse. 29, 281\u2013299.", "journal-title": "Am. J. Drug Alcohol Abuse."}, {"key": "7_CR75", "doi-asserted-by": "crossref", "first-page": "1108", "DOI": "10.1124/mol.59.5.1108", "volume": "59", "author": "A. J. Smith", "year": "2001", "unstructured": "Smith, A. J., Alder, L., Silk, J., et al. (2001) Effect of a subunit on allosteric modulation of ion channel function in stably expressed human recombinant \u03b3-aminobutyric acidA receptors determined using 36Cl ion flux. Mol. Pharmacol. 59, 1108\u20131118.", "journal-title": "Mol. Pharmacol."}], "container-title": ["The GABA Receptors", "The Receptors"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59745-465-0_7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 4]], "date-time": "2019-05-04T14:10:26Z", "timestamp": 1556979026000}, "score": 23.872597, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588298133"], "references-count": 75, "URL": "http://dx.doi.org/10.1007/978-1-59745-465-0_7", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T14:34:19Z", "timestamp": 1575210859253}, "reference-count": 0, "publisher": "China Science Publishing & Media Ltd.", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Psychologica Sinica"], "published-print": {"date-parts": [[2013, 4, 16]]}, "DOI": "10.3724/sp.j.1041.2012.01318", "type": "journal-article", "created": {"date-parts": [[2013, 4, 16]], "date-time": "2013-04-16T07:35:28Z", "timestamp": 1366097728000}, "page": "1318-1328", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Role of Hippocampal 5-HT1A Receptor and Its Modulation to NMDA Receptor and AMPA Receptor in Depression Induced by Chronic Unpredictable Mild Stress"], "prefix": "10.3724", "volume": "44", "author": [{"given": "Li-Min", "family": "WEN", "sequence": "first", "affiliation": []}, {"given": "Shu-Cheng", "family": "AN", "sequence": "additional", "affiliation": []}, {"given": "Hui", "family": "LIU", "sequence": "additional", "affiliation": []}], "member": "2026", "container-title": ["Acta Psychologica Sinica"], "language": "en", "deposited": {"date-parts": [[2013, 4, 16]], "date-time": "2013-04-16T07:36:06Z", "timestamp": 1366097766000}, "score": 23.068247, "subtitle": ["Role of Hippocampal 5-HT1A Receptor and Its Modulation to NMDA Receptor and AMPA Receptor in Depression Induced by Chronic Unpredictable Mild Stress"], "issued": {"date-parts": [[2013, 4, 16]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 10, 20]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.3724/sp.j.1041.2012.01318", "ISSN": ["0439-755X"], "issn-type": [{"value": "0439-755X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T13:10:11Z", "timestamp": 1575292211460}, "reference-count": 31, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Pharmacol Exp Ther"], "published-print": {"date-parts": [[2018, 7]]}, "DOI": "10.1124/jpet.118.249250", "type": "journal-article", "created": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T21:00:10Z", "timestamp": 1525294810000}, "page": "145-157", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys"], "prefix": "10.1124", "volume": "366", "author": [{"given": "Angela N.", "family": "Duke", "sequence": "first", "affiliation": []}, {"given": "Zhiqiang", "family": "Meng", "sequence": "additional", "affiliation": []}, {"given": "Donna M.", "family": "Platt", "sequence": "additional", "affiliation": []}, {"given": "John R.", "family": "Atack", "sequence": "additional", "affiliation": []}, {"given": "Gerard R.", "family": "Dawson", "sequence": "additional", "affiliation": []}, {"given": "David S.", "family": "Reynolds", "sequence": "additional", "affiliation": []}, {"given": "V. V. N. Phani Babu", "family": "Tiruveedhula", "sequence": "additional", "affiliation": []}, {"given": "Guanguan", "family": "Li", "sequence": "additional", "affiliation": []}, {"given": "Michael Rajesh", "family": "Stephen", "sequence": "additional", "affiliation": []}, {"given": "Werner", "family": "Sieghart", "sequence": "additional", "affiliation": []}, {"given": "James M.", "family": "Cook", "sequence": "additional", "affiliation": []}, {"given": "James K.", "family": "Rowlett", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2018, 5, 2]]}, "reference": [{"key": "2019080512312302000_366.1.145.1", "DOI": "10.1097/00000542-200204000-00031", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.2", "DOI": "10.2174/156802611795371350", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.3", "DOI": "10.1177/0269881109354928", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.4", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1177/0269881109354927", "article-title": "MRK-409, a GABAA receptor subtype-selective agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in man", "volume": "25", "author": "Atack", "year": "2011", "journal-title": "J Psychopharmacol"}, {"key": "2019080512312302000_366.1.145.5", "doi-asserted-by": "crossref", "first-page": "2492", "DOI": "10.1038/npp.2016.49", "article-title": "A pharmacogenetic \u2018restriction-of-function\u2019 approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice", "volume": "41", "author": "Behlke", "year": "2016", "journal-title": "Neuropsychopharmacology"}, {"key": "2019080512312302000_366.1.145.6", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1016/j.neuropharm.2010.11.026", "article-title": "HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain", "volume": "60", "author": "Di Lio", "year": "2011", "journal-title": "Neuropharmacology"}, {"key": "2019080512312302000_366.1.145.7", "first-page": "1246", "article-title": "Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability", "volume": "255", "author": "Evans", "year": "1990", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019080512312302000_366.1.145.8", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1007/s00213-010-2142-y", "article-title": "Contribution of GABA(A) receptors containing \u03b13 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys", "volume": "215", "author": "Fischer", "year": "2011", "journal-title": "Psychopharmacology (Berl)"}, {"key": "2019080512312302000_366.1.145.9", "DOI": "10.1016/j.neuropharm.2010.08.011", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.10", "DOI": "10.1021/jm990341r", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.11", "DOI": "10.1007/BF02244836", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.12", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1007/s00213-005-0060-1", "article-title": "A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist", "volume": "180", "author": "Lingford-Hughes", "year": "2005", "journal-title": "Psychopharmacology (Berl)"}, {"key": "2019080512312302000_366.1.145.13", "DOI": "10.1126/science.290.5489.131", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.14", "DOI": "10.1038/75761", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.15", "doi-asserted-by": "crossref", "first-page": "708", "DOI": "10.1111/bph.14119", "article-title": "Pharmacology in translation: the preclinical and early clinical profile of the novel \u03b12/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865", "volume": "175", "author": "Nickolls", "year": "2018", "journal-title": "Br J Pharmacol"}, {"key": "2019080512312302000_366.1.145.16", "DOI": "10.1002/(SICI)1098-2345(1998)46:3<213::AID-AJP3>3.0.CO;2-L", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.17", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1002/ajp.1350280205", "article-title": "Adjustments and adaptations to indoor and outdoor environments: continuity and change in young adult rhesus monkeys", "volume": "28", "author": "Novak", "year": "1992", "journal-title": "Am J Primatol"}, {"key": "2019080512312302000_366.1.145.18", "first-page": "10.5.1", "article-title": "Models of neurological disease (substance abuse): self-administration in monkeys", "volume-title": "Curr Protoc Pharmacol", "volume": "56", "author": "Platt", "year": "2011"}, {"key": "2019080512312302000_366.1.145.19", "DOI": "10.1007/s00213-002-1189-9", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.20", "DOI": "10.1021/jm801652d", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.21", "DOI": "10.1007/s00213-005-0228-8", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.22", "DOI": "10.1073/pnas.0405621102", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.23", "DOI": "10.1038/44579", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.24", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1038/nrn1496", "article-title": "Molecular and neuronal substrates for general anesthetics", "volume": "5", "author": "Rudolph", "year": "2004", "journal-title": "Nat Neurosci Rev"}, {"key": "2019080512312302000_366.1.145.25", "DOI": "10.1038/nrd3502", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.26", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1111/acer.12018", "article-title": "Modulation of \u03b15 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys", "volume": "37", "author": "R\u00fcedi-Bettschen", "year": "2013", "journal-title": "Alcohol Clin Exp Res"}, {"key": "2019080512312302000_366.1.145.27", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1038/npp.2012.265", "article-title": "Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys", "volume": "38", "author": "Shinday", "year": "2013", "journal-title": "Neuropsychopharmacology"}, {"key": "2019080512312302000_366.1.145.28", "DOI": "10.1016/j.tips.2012.08.003", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.29", "DOI": "10.1016/j.tins.2011.01.004", "doi-asserted-by": "publisher"}, {"key": "2019080512312302000_366.1.145.30", "first-page": "285", "article-title": "Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons", "volume": "9", "author": "Weerts", "year": "1998", "journal-title": "Behav Pharmacol"}, {"key": "2019080512312302000_366.1.145.31", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0091-3057(80)90430-X", "article-title": "Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys", "volume": "12", "author": "Yanagita", "year": "1980", "journal-title": "Pharmacol Biochem Behav"}], "container-title": ["Journal of Pharmacology and Experimental Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/jpet.118.249250", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 5]], "date-time": "2019-08-05T19:34:55Z", "timestamp": 1565033695000}, "score": 22.557663, "issued": {"date-parts": [[2018, 5, 2]]}, "references-count": 31, "journal-issue": {"published-online": {"date-parts": [[2018, 6, 18]]}, "published-print": {"date-parts": [[2018, 7]]}, "issue": "1"}, "alternative-id": ["10.1124/jpet.118.249250"], "URL": "http://dx.doi.org/10.1124/jpet.118.249250", "relation": {"cites": []}, "ISSN": ["0022-3565", "1521-0103"], "issn-type": [{"value": "0022-3565", "type": "print"}, {"value": "1521-0103", "type": "electronic"}], "subject": ["Molecular Medicine", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:44:56Z", "timestamp": 1574235896799}, "reference-count": 31, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs: Education, Prevention and Policy"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1080/09687630600613520", "type": "journal-article", "created": {"date-parts": [[2006, 10, 12]], "date-time": "2006-10-12T22:05:07Z", "timestamp": 1160690707000}, "page": "409-415", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Out of crime and into treatment?: The criminalization of contemporary drug policy sinceTackling Drugs Together"], "prefix": "10.1080", "volume": "13", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 10]]}, "reference": [{"key": "CIT0001", "author": "ACOP (Association of Chief Officers of Probation)", "year": "1995", "volume-title": "ACOP response to Tackling Drugs Together"}, {"key": "CIT0002", "author": "ACPO (Association of Chief Officers of Police)", "year": "1995", "volume-title": "Government Green Paper \u2018Tackling Drugs Together\u2019: The response of the Police Service in England"}, {"key": "CIT0003", "author": "ADSS (Association of Directors of Social Services)", "year": "1995", "volume-title": "Tackling Drugs Together: Response of the Association of Directors of Social Services"}, {"key": "CIT0004", "author": "All Party Parliamentary Drugs Misuse Group", "year": "1995", "volume-title": "Comments from the All-Party Parliamentary Drugs Misuse Group on the Government's Consultation Document, \u2018Tackling Drugs Together\u2019"}, {"key": "CIT0005", "author": "Barnes M", "year": "2004", "volume-title": "Speech on drug treatment 2004"}, {"key": "CIT0006", "DOI": "10.1080/09687630110085709", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Bennett T", "year": "1998", "volume-title": "Drugs and crime: The results of research on drug testing and interviewing arrestees. Home Office Research Study 183"}, {"key": "CIT0008", "author": "Blagg H", "first-page": "204", "year": "1988", "volume-title": "Communities and crime reduction"}, {"key": "CIT0009", "author": "Crawford A", "year": "1997", "volume-title": "The local governance of crime: Appeals to community and partnerships"}, {"key": "CIT0010", "author": "Crawford A", "year": "1998", "volume-title": "Crime prevention and community safety"}, {"key": "CIT0011", "author": "Department for Education and Skills", "year": "2004", "volume-title": "Drugs: Guidance for schools"}, {"key": "CIT0012", "DOI": "10.1057/9780230006133", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "author": "Gossop M", "year": "1995", "volume-title": "The National Treatment Outcome Research Study: A report prepared for the task-force"}, {"key": "CIT0014", "author": "H. M. Government", "year": "1995", "volume-title": "Tackling drugs together: A strategy for England 1995\u20131998 (CM 2846)"}, {"key": "CIT0015", "author": "H. M. Government", "year": "1998", "volume-title": "Tackling drugs to build a better Britain: The government's ten year strategy for tackling drugs misuse (CM 3945)"}, {"key": "CIT0016", "author": "H. M. Government", "year": "2002", "volume-title": "Updated drug strategy 2002"}, {"key": "CIT0017", "author": "Home Office Drug Strategy Directorate", "year": "2004", "volume-title": "(Drug Strategy Progress Report 2004)"}, {"key": "CIT0018", "author": "Hough M", "year": "2003", "volume-title": "Home Office Findings 184"}, {"key": "CIT0019", "author": "Howard R", "year": "1994", "volume-title": "Across the divide: Building community partnerships to tackle drug misuse"}, {"key": "CIT0020", "author": "Joseph Rowntree Foundation", "year": "2004", "volume-title": "Drug testing in the workplace: The report of the Independent Inquiry into Drug Testing at Work"}, {"key": "CIT0021", "author": "Labour Party", "year": "1996", "volume-title": "Breaking the vicious circle: Labour's proposals to tackle drug related crime"}, {"key": "CIT0022", "author": "LDPF (London Drug Policy Forum)", "year": "1995", "volume-title": "Joint response from the London Drugs Policy Forum, Association of London Authorities and the London Boroughs Association and the London Borough's Grants Committee"}, {"key": "CIT0023", "author": "LGDF (Local Government Drugs Forum)", "year": "1995", "volume-title": "Response to the Green Paper \u2018Tackling Drugs Together\u2019"}, {"key": "CIT0024", "author": "National Audit Office", "year": "2004", "volume-title": "(Report by the Comptroller and Auditor General HC 366 Session 2003\u20132004: 26 March 2004)"}, {"key": "CIT0025", "author": "Phoenix House", "year": "1995", "volume-title": "A response to the consultation paper from Phoenix House"}, {"key": "CIT0026", "DOI": "10.7748/ns2000.03.14.27.38.c2793", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "author": "Release", "year": "1995", "volume-title": "Response to the Government Green Paper"}, {"key": "CIT0028", "author": "SCODA (Standing Conference on Drug Abuse)", "year": "1995", "volume-title": "Tackling Drugs Together: A response from drug service providers"}, {"key": "CIT0029", "author": "Stenson K", "volume": "45", "first-page": "1", "year": "1994", "journal-title": "Youth and Policy"}, {"key": "CIT0030", "author": "Stevens A", "year": "2005", "volume-title": "Reducing drug related crime: An overview of the global evidence"}, {"key": "CIT0031", "author": "Turning Point", "year": "1995", "volume-title": "A response to the Green Paper \u2018Tackling Drugs Together\u2019"}], "container-title": ["Drugs: Education, Prevention and Policy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/09687630600613520", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T06:42:51Z", "timestamp": 1481611371000}, "score": 21.27568, "issued": {"date-parts": [[2006, 1]]}, "references-count": 31, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 10]]}, "published-print": {"date-parts": [[2006, 1]]}, "issue": "5"}, "alternative-id": ["10.1080/09687630600613520"], "URL": "http://dx.doi.org/10.1080/09687630600613520", "relation": {"cites": []}, "ISSN": ["0968-7637", "1465-3370"], "issn-type": [{"value": "0968-7637", "type": "print"}, {"value": "1465-3370", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:53:19Z", "timestamp": 1574301199858}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs: educ., prevention & policy", "CDEP"], "published-print": {"date-parts": [[2000, 11]]}, "DOI": "10.1080/713660127", "type": "journal-article", "created": {"date-parts": [[2007, 6, 25]], "date-time": "2007-06-25T14:04:07Z", "timestamp": 1182780247000}, "page": "393-408", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prison Drugs Policy Since 1980: shifting agendas and policy networks"], "prefix": "10.1080", "volume": "7", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "301", "container-title": ["Drugs: education, prevention and policy"], "language": "en", "deposited": {"date-parts": [[2007, 6, 25]], "date-time": "2007-06-25T14:04:08Z", "timestamp": 1182780248000}, "score": 21.27568, "issued": {"date-parts": [[2000, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 11]]}, "issue": "4"}, "alternative-id": ["713660127"], "URL": "http://dx.doi.org/10.1080/713660127", "ISSN": ["0968-7637"], "issn-type": [{"value": "0968-7637", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:30:50Z", "timestamp": 1574397050078}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs: Education, Prevention and Policy"], "published-print": {"date-parts": [[2000, 1]]}, "DOI": "10.1080/dep.7.4.393.408", "type": "journal-article", "created": {"date-parts": [[2009, 12, 7]], "date-time": "2009-12-07T14:52:54Z", "timestamp": 1260197574000}, "page": "393-408", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Prison Drugs Policy Since 1980: shifting agendas and policy networks"], "prefix": "10.1080", "volume": "7", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 10]]}, "container-title": ["Drugs: Education, Prevention and Policy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/dep.7.4.393.408", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T09:23:04Z", "timestamp": 1481620984000}, "score": 21.27568, "issued": {"date-parts": [[2000, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 10]]}, "published-print": {"date-parts": [[2000, 1]]}, "issue": "4"}, "alternative-id": ["10.1080/dep.7.4.393.408"], "URL": "http://dx.doi.org/10.1080/dep.7.4.393.408", "ISSN": ["0968-7637", "1465-3370"], "issn-type": [{"value": "0968-7637", "type": "print"}, {"value": "1465-3370", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T20:22:21Z", "timestamp": 1574713341635}, "reference-count": 0, "publisher": "[s.n.]", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1982]]}, "DOI": "10.5962/bhl.title.104975", "type": "monograph", "created": {"date-parts": [[2015, 7, 23]], "date-time": "2015-07-23T06:03:22Z", "timestamp": 1437631402000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["The laminar organization of the lateral geniculate body and the striate cortex in the squirrel monkey (Saimiri sciureus) /"], "prefix": "10.5962", "author": [{"given": "David", "family": "Fitzpatrick", "sequence": "first", "affiliation": []}, {"name": "Duke University.", "sequence": "additional", "affiliation": []}], "member": "3444", "deposited": {"date-parts": [[2015, 7, 23]], "date-time": "2015-07-23T06:03:23Z", "timestamp": 1437631403000}, "score": 21.146166, "issued": {"date-parts": [[1982]]}, "references-count": 0, "URL": "http://dx.doi.org/10.5962/bhl.title.104975"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:50:34Z", "timestamp": 1574797834420}, "publisher-location": "London", "reference-count": 0, "publisher": "Palgrave Macmillan UK", "isbn-type": [{"value": "9781349430390", "type": "print"}, {"value": "9780230006133", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1057/9780230006133_1", "type": "book-chapter", "created": {"date-parts": [[2016, 5, 19]], "date-time": "2016-05-19T03:29:59Z", "timestamp": 1463628599000}, "page": "1-30", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysing Prison Drugs Policy: Problems, Networks and Contexts"], "prefix": "10.1057", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Drugs, Prisons and Policy-Making"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1057/9780230006133_1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 5, 19]], "date-time": "2016-05-19T03:30:00Z", "timestamp": 1463628600000}, "score": 20.888515, "issued": {"date-parts": [[2003]]}, "ISBN": ["9781349430390", "9780230006133"], "references-count": 0, "URL": "http://dx.doi.org/10.1057/9780230006133_1"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:37:24Z", "timestamp": 1574145444668}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 3, 1]], "date-time": "1988-03-01T00:00:00Z", "timestamp": 573177600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[1988, 3]]}, "DOI": "10.1016/0006-2952(88)90502-3", "type": "journal-article", "created": {"date-parts": [[2002, 12, 13]], "date-time": "2002-12-13T23:18:04Z", "timestamp": 1039821484000}, "page": "1009-1014", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Interactions of lipids with peripheral-type benzodiazepine receptors"], "prefix": "10.1016", "volume": "37", "author": [{"given": "Kevin", "family": "Beaumont", "sequence": "first", "affiliation": []}, {"given": "Roman", "family": "Skowronski", "sequence": "additional", "affiliation": []}, {"given": "Duke A.", "family": "Vaughn", "sequence": "additional", "affiliation": []}, {"given": "Darrell D.", "family": "Fanestil", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006295288905023?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006295288905023?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T02:23:25Z", "timestamp": 1554171805000}, "score": 20.579275, "issued": {"date-parts": [[1988, 3]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[1988, 3]]}, "issue": "6"}, "alternative-id": ["0006295288905023"], "URL": "http://dx.doi.org/10.1016/0006-2952(88)90502-3", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:59:06Z", "timestamp": 1574801946012}, "reference-count": 51, "publisher": "Informa UK Limited", "issue": "2", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Drugs: Education, Prevention and Policy"], "published-print": {"date-parts": [[2016, 3, 3]]}, "DOI": "10.3109/09687637.2016.1153604", "type": "journal-article", "created": {"date-parts": [[2016, 5, 24]], "date-time": "2016-05-24T08:50:53Z", "timestamp": 1464079853000}, "page": "89-92", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Drugs in prisons: Exploring use, control, treatment and policy"], "prefix": "10.3109", "volume": "23", "author": [{"given": "Torsten", "family": "Kolind", "sequence": "first", "affiliation": []}, {"given": "Karen", "family": "Duke", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2016, 5, 23]]}, "reference": [{"key": "CIT0001", "author": "Australian Institute of Health and Welfare (AIHW)", "year": "2013", "volume-title": "The Health of Australia\u2019s Prisoners 2012"}, {"key": "CIT0002", "DOI": "10.3109/09687637.2015.1016397", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1046/j.1360-0443.2002.00229.x", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1093/bjc/azq056", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "author": "Butler T.", "year": "2011", "volume-title": "National prison entrants\u2019 blood borne virus and risk behaviour survey 2004, 2007, and 2010"}, {"key": "CIT0006", "author": "CASA", "year": "2010", "volume-title": "Behind Bars II: Substance abuse and America\u2019s prison population"}, {"key": "CIT0007", "unstructured": "Codd, M., Mehegan, J., Kelleher, C. & Drummond, A. (2016). Use of hierarchical cluster analysis to classify prisons in Ireland into mutually exclusive drug-use risk categories.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2016.1146232", "doi-asserted-by": "crossref"}, {"key": "CIT0008", "DOI": "10.1111/1468-2311.t01-1-00273", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1177/1462474505057122", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1111/j.1468-2311.2006.00428.x", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1057/9780230006133", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1080/09687630600613520", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1017/CBO9781139162142.016", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "author": "Duke K.", "volume-title": "Handbook on drug and alcohol studies \u2013 social science perspectives"}, {"key": "CIT0016", "unstructured": "Elison, S., Weston, S., Davies, G., Dugdale, S. & Ward, J. (2016). Findings from mixed-methods feasibility and effectiveness evaluations of the \u2018Breaking Free Online\u2019 treatment and recovery programme for substance misuse in prisons.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1090397", "doi-asserted-by": "crossref"}, {"key": "CIT0018", "author": "EMCDDA", "year": "2012", "volume-title": "Prisons and Drugs in Europe: The problem and responses"}, {"key": "CIT0019", "DOI": "10.1111/j.1360-0443.2007.02081.x", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1111/j.1360-0443.2006.01316.x", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1007/s00127-010-0184-4", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "author": "Garland D.", "year": "2001", "volume-title": "The culture of control. Crime and social order in contemporary society", "DOI": "10.7208/chicago/9780226190174.001.0001", "doi-asserted-by": "crossref"}, {"key": "CIT0023", "author": "Garland D.", "year": "2001", "volume-title": "Punishment and welfare"}, {"key": "CIT0024", "DOI": "10.1177/1477370813495758", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "author": "Indig D.", "year": "2010", "volume-title": "2009 NSW Inmate Health Survey: Key findings report"}, {"key": "CIT0026", "DOI": "10.1080/09581590400027478", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/j.drugpo.2015.04.014", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1177/1477370812471247", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "unstructured": "Kolind, T., Holm, K., Duff, C. & Frank, V.A. (2016). Three enactments of drugs in Danish prison drug treatment: Illegal drugs, medicine and constrainers.Drugs:Education Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1109608", "doi-asserted-by": "crossref"}, {"key": "CIT0029", "unstructured": "Mazhnaya, A., Bojko, M., Marcus, R., Filippovych, S., Islam, Z., Dvoriak, S. & Altice, F. (2016). In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine.Drugs:Education Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1127327", "doi-asserted-by": "crossref"}, {"key": "CIT0030", "unstructured": "McKeganey, N., Russell, C., Page, G., Hamilton Barclay, T., Lloyd, C., Liebling, A. \u2026 Templeton, L. (2016). The characteristics of prisoners receiving treatment within drug recovery wings in England and Wales.Drugs:Education, Prevention and Policy(this issue)"}, {"key": "CIT0031", "DOI": "10.1186/s12889-015-2421-y", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "author": "Ministry of Health", "year": "2006", "volume-title": "Results from the Prisoner Health Survey, 2005"}, {"key": "CIT0033", "author": "Ministry of Justice", "year": "2010", "volume-title": "Compendium of reoffending statistics and analysis"}, {"key": "CIT0034", "DOI": "10.1177/1462474514527149", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "unstructured": "Mj\u00e5land, K. (2016). Exploring prison drug use in the context of prison based drug rehabilitation.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1136265", "doi-asserted-by": "crossref"}, {"key": "CIT0036", "unstructured": "Moazen, B., Shahbazi, M., Rezaei, F., Shokouhi, M., Farnia, M., Moradi, G. & Dolan, K. (2016). Views of prison staff towards needle exchange program in prisons: A qualitative study in Iran.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2016.1149147", "doi-asserted-by": "crossref"}, {"key": "CIT0037", "unstructured": "Mohammed, Z., Hughes, G., Hearty, P. & Wright, N. (2016). The perceived and actual consequences of intranasal administration of buprenorphine or burprenorphine-naloxone by prisoners.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1085491", "doi-asserted-by": "crossref"}, {"key": "CIT0038", "DOI": "10.3109/09687637.2014.947564", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1093/bjc/azm072", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1016/j.drugpo.2013.05.001", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.3109/09687637.2014.993921", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "author": "Seddon T.", "year": "2012", "volume-title": "Tough choices. Risk, security, and the criminalization of drug policy"}, {"key": "CIT0043", "author": "St\u00f6ver H.", "first-page": "85", "year": "2007", "volume-title": "Health in prisons: A WHO guide to the essentials in prison health"}, {"key": "CIT0044", "unstructured": "Stover, H. & Hariga, F. (2016). Prison-based needle and syringe programmes (PNSP) \u2013 still highly controversial after all these years.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2016.1148117", "doi-asserted-by": "crossref"}, {"key": "CIT0045", "DOI": "10.1111/j.1360-0443.2006.01475.x", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "author": "Sykes G.", "year": "1958", "volume-title": "The society of captives"}, {"key": "CIT0047", "unstructured": "Tompkins, C. (2016). \u2018There\u2019s that many people selling it:\u2019 Exploring the nature, organisation and maintenance of prison drug markets in England.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1085490", "doi-asserted-by": "crossref"}, {"key": "CIT0048", "author": "UNODC", "year": "2008", "volume-title": "Women and HIV in prison settings"}, {"key": "CIT0049", "author": "Wheatley M.", "first-page": "399", "year": "2007", "volume-title": "Handbook on prisons"}, {"key": "CIT0050", "author": "World Health Organization", "year": "2004", "volume-title": "Evidence for action on HIV/AIDS and injecting drug use. Policy brief: Provision of sterile injecting equipment to reduce HIV transmission"}, {"key": "CIT0051", "author": "WHO", "year": "2014", "volume-title": "Prisons and Health"}, {"key": "CIT0052", "unstructured": "Zurhold, H. & Stover, H. (2016). Provision of harm reduction and drug treatment services in custodial settings \u2013 findings from the European ACCESS study.Drugs:Education, Prevention and Policy(this issue)", "DOI": "10.3109/09687637.2015.1112363", "doi-asserted-by": "crossref"}], "container-title": ["Drugs: Education, Prevention and Policy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/09687637.2016.1153604", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 8]], "date-time": "2019-09-08T18:43:45Z", "timestamp": 1567968225000}, "score": 20.13619, "issued": {"date-parts": [[2016, 3, 3]]}, "references-count": 51, "journal-issue": {"published-online": {"date-parts": [[2016, 5, 10]]}, "published-print": {"date-parts": [[2016, 3, 3]]}, "issue": "2"}, "alternative-id": ["10.3109/09687637.2016.1153604"], "URL": "http://dx.doi.org/10.3109/09687637.2016.1153604", "relation": {"cites": []}, "ISSN": ["0968-7637", "1465-3370"], "issn-type": [{"value": "0968-7637", "type": "print"}, {"value": "1465-3370", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idep20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idep20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T07:01:36Z", "timestamp": 1575183696252}, "reference-count": 38, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs: Education, Prevention and Policy"], "published-print": {"date-parts": [[2005, 1]]}, "DOI": "10.1080/09687630500281873", "type": "journal-article", "created": {"date-parts": [[2005, 10, 26]], "date-time": "2005-10-26T20:45:48Z", "timestamp": 1130359548000}, "page": "417-430", "source": "Crossref", "is-referenced-by-count": 1, "title": ["D\u00e9j\u00e0 vu? Opportunities and obstacles in developing alcohol policy in English prisons"], "prefix": "10.1080", "volume": "12", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 10]]}, "reference": [{"key": "CIT0001", "author": "Advisory Council on the Misuse of Drugs (ACMD)", "year": "1996", "volume-title": "Drug misusers and the criminal justice system, part three: Drug misusers and the prison system\u2014an integrated approach"}, {"key": "CIT0002", "author": "All Party Group on Alcohol Misuse", "year": "1995", "volume-title": "Alcohol and crime: Breaking the link"}, {"key": "CIT0004", "author": "Bennett T", "year": "1998", "volume-title": "Drugs and crime: The results of research on drug testing and interviewing arrestees"}, {"key": "CIT0005", "author": "Black J", "year": "2002", "volume-title": "Prison service alcohol strategy: Alcohol treatment and interventions. A paper prepared by Alcohol Concern to inform the development of the Prison Service Alcohol Strategy"}, {"key": "CIT0006", "author": "Borrill J", "first-page": "49", "year": "2003", "volume-title": "Prisoners\u2019 drug use and treatment: Seven research studies"}, {"key": "CIT0007", "author": "Budd T", "year": "2003", "volume-title": "Alcohol-related assault: Findings from the British Crime Survey"}, {"key": "CIT0008", "author": "Bullock T", "first-page": "71", "year": "2003", "volume-title": "Prisoners\u2019 drug use and treatment: Seven research studies"}, {"key": "CIT0009", "author": "Deehan A", "year": "1999", "volume-title": "Alcohol and crime: Taking stock"}, {"key": "CIT0010", "author": "Drug Prevention and Advisory Service (DPAS)", "year": "1999", "volume-title": "Drug interventions in the criminal justice system: Guidance manual"}, {"key": "CIT0011", "DOI": "10.1057/9780230006133", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "author": "Finney A", "year": "2004", "volume-title": "Violence in the night-time economy: Key findings from the research"}, {"key": "CIT0013", "author": "Finney A", "year": "2004", "volume-title": "Alcohol and sexual violence: Key findings from the research"}, {"key": "CIT0014", "author": "Finney A", "year": "2004", "volume-title": "Alcohol and intimate partner violence: Key findings from the research"}, {"key": "CIT0015", "DOI": "10.1080/09687630410001731239", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "author": "Health Advisory Committee for the Prison Service", "year": "1997", "volume-title": "Alcohol misuse and the prison community"}, {"key": "CIT0028", "author": "Hobbs D", "year": "2003", "volume-title": "Bouncers: Violence and governance in the night-time economy"}, {"issue": "4", "key": "CIT0033", "first-page": "499", "volume": "28", "author": "MacMillan J", "year": "1993", "journal-title": "Alcohol and Alcoholism"}, {"key": "CIT0034", "author": "Maguire M", "year": "2003", "volume-title": "Reducing alcohol-related violence and disorder: An evaluation of the TASC project"}, {"key": "CIT0035", "author": "Martin C", "year": "2000", "volume-title": "Drug treatment in prison: An evaluation of the RAPt treatment programme"}, {"key": "CIT0036", "author": "Martin C", "first-page": "97", "year": "2003", "volume-title": "Prisoners\u2019 drug use and treatment: Seven research studies"}, {"key": "CIT0037", "author": "Mason P", "first-page": "113", "year": "2003", "volume-title": "Prisoners\u2019 drug use and treatment: Seven research studies"}, {"key": "CIT0038", "DOI": "10.1111/j.1360-0443.1989.tb00788.x", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1136/bmj.328.7445.905", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "author": "Prison Reform Trust", "year": "2004", "volume-title": "Alcohol and reoffending\u2014who cares?"}, {"key": "CIT0042", "author": "Purser B", "year": "2001", "volume-title": "Drinking in second and subsequent generation Black and Asian communities in the English Midlands"}, {"key": "CIT0043", "author": "Raistrick D", "year": "1999", "volume-title": "Tackling alcohol together: The evidence base for UK alcohol policy"}, {"key": "CIT0044", "author": "Richardson A", "year": "2003", "volume-title": "Alcohol, crime and disorder: A study of young adults"}, {"key": "CIT0045", "DOI": "10.1111/j.1360-0443.2004.00803.x", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "author": "Scottish Prison Service", "year": "2003", "volume-title": "Addictions inclusion policy manual"}, {"key": "CIT0047", "author": "Singleton N", "year": "1999", "volume-title": "Substance misuse among prisoners in England and Wales"}, {"key": "CIT0048", "author": "Singleton N", "year": "2003", "volume-title": "Drug-related mortality among newly released offenders"}, {"key": "CIT0049", "DOI": "10.1136/bmj.328.7445.907", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "author": "South N", "first-page": "914", "year": "2002", "volume-title": "The Oxford handbook of criminology"}, {"key": "CIT0051", "DOI": "10.1093/acprof:oso/9780198258186.001.0001", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "author": "Sumner M", "year": "1994", "volume-title": "Low in alcohol: A review of international research into alcohol's role in crime causation"}, {"key": "CIT0053", "DOI": "10.1093/oxfordjournals.bjc.a014152", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "author": "Webster R", "year": "1995", "volume-title": "Breaking into the system: A guide for alcohol services on partnership with the police, probation and prison services"}, {"issue": "2", "key": "CIT0055", "first-page": "157", "volume": "17", "author": "Wright KN", "year": "1993", "journal-title": "Alcohol Health and Research World"}], "container-title": ["Drugs: Education, Prevention and Policy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/09687630500281873", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T06:42:22Z", "timestamp": 1481611342000}, "score": 20.001038, "issued": {"date-parts": [[2005, 1]]}, "references-count": 38, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 10]]}, "published-print": {"date-parts": [[2005, 1]]}, "issue": "5"}, "alternative-id": ["10.1080/09687630500281873"], "URL": "http://dx.doi.org/10.1080/09687630500281873", "relation": {"cites": []}, "ISSN": ["0968-7637", "1465-3370"], "issn-type": [{"value": "0968-7637", "type": "print"}, {"value": "1465-3370", "type": "electronic"}], "subject": ["Medicine (miscellaneous)", "Health(social science)"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T12:49:06Z", "timestamp": 1574772546570}, "reference-count": 53, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 4, 1]], "date-time": "2016-04-01T00:00:00Z", "timestamp": 1459468800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100007397", "name": "UK", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/501100000765", "name": "UCL", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2016, 4]]}, "DOI": "10.1016/j.ejphar.2016.03.007", "type": "journal-article", "created": {"date-parts": [[2016, 3, 5]], "date-time": "2016-03-05T19:59:50Z", "timestamp": 1457207990000}, "page": "136-146", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides"], "prefix": "10.1016", "volume": "777", "author": [{"given": "Chiu Chin", "family": "Ng", "sequence": "first", "affiliation": []}, {"given": "Rujee K.", "family": "Duke", "sequence": "additional", "affiliation": []}, {"given": "Tina", "family": "Hinton", "sequence": "additional", "affiliation": []}, {"given": "Graham A.R.", "family": "Johnston", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299916301200?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299916301200?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 5]], "date-time": "2019-09-05T07:57:00Z", "timestamp": 1567670220000}, "score": 19.921837, "issued": {"date-parts": [[2016, 4]]}, "references-count": 53, "alternative-id": ["S0014299916301200"], "URL": "http://dx.doi.org/10.1016/j.ejphar.2016.03.007", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides", "name": "articletitle", "label": "Article Title"}, {"value": "European Journal of Pharmacology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ejphar.2016.03.007", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2016 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:57:03Z", "timestamp": 1574283423178}, "publisher-location": "London", "reference-count": 0, "publisher": "Palgrave Macmillan UK", "isbn-type": [{"value": "9781349430390", "type": "print"}, {"value": "9780230006133", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1057/9780230006133", "type": "book", "created": {"date-parts": [[2009, 3, 4]], "date-time": "2009-03-04T10:04:43Z", "timestamp": 1236161083000}, "source": "Crossref", "is-referenced-by-count": 13, "title": ["Drugs, Prisons and Policy-Making"], "prefix": "10.1057", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "297", "link": [{"URL": "http://link.springer.com/content/pdf/10.1057/9780230006133.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1057/9780230006133", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T23:37:07Z", "timestamp": 1554248227000}, "score": 19.893621, "issued": {"date-parts": [[2003]]}, "ISBN": ["9781349430390", "9780230006133"], "references-count": 0, "URL": "http://dx.doi.org/10.1057/9780230006133"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T03:23:15Z", "timestamp": 1575256995574}, "reference-count": 7, "publisher": "Cambridge University Press (CUP)", "issue": "3", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2009, 4, 6]], "date-time": "2009-04-06T00:00:00Z", "timestamp": 1238976000000}, "delay-in-days": 28404, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Parasitology"], "published-print": {"date-parts": [[1931, 7]]}, "abstract": "<jats:p>In the <jats:italic>Final Report of the League of Nations International Commission on Sleeping Sickness</jats:italic> (1928) certain tentative conclusions were expressed about the behaviour of <jats:italic>T. gambiense</jats:italic>, recently isolated from man, in the blood of monkeys and of certain domestic ruminants. These conclusions, which were intended primarily to serve as a basis for further researches, were set forth in the Summary of Part I of that Report, and read as follows:</jats:p>", "DOI": "10.1017/s0031182000013718", "type": "journal-article", "created": {"date-parts": [[2013, 7, 30]], "date-time": "2013-07-30T12:53:19Z", "timestamp": 1375188799000}, "page": "325-345", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Trypanosoma gambiense in Monkeys and Ruminants; Prolonged Infection, Immunity and Superinfection"], "prefix": "10.1017", "volume": "23", "author": [{"given": "H. Lyndhurst", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2009, 4, 6]]}, "reference": [{"key": "S0031182000013718_ref006", "DOI": "10.1017/S0031182000011343", "doi-asserted-by": "publisher"}, {"key": "S0031182000013718_ref003", "DOI": "10.1080/00034983.1924.11684426", "doi-asserted-by": "publisher"}, {"key": "S0031182000013718_ref004", "author": "Duke", "year": "1928", "volume-title": "Final Report of the League of Nations International Commission on Human Trypanosomiasis"}, {"key": "S0031182000013718_ref005", "DOI": "10.1017/S003118200001180X", "doi-asserted-by": "publisher"}, {"key": "S0031182000013718_ref002", "DOI": "10.1098/rspb.1912.0053", "doi-asserted-by": "publisher"}, {"key": "S0031182000013718_ref007", "DOI": "10.1098/rstb.1913.0005", "doi-asserted-by": "publisher"}, {"key": "S0031182000013718_ref001", "author": "Bruce", "year": "1911", "journal-title": "Rep. Sleeping Sickness Commission of the Roy. Soc."}], "container-title": ["Parasitology"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0031182000013718", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 9]], "date-time": "2019-06-09T19:20:30Z", "timestamp": 1560108030000}, "score": 19.715096, "issued": {"date-parts": [[1931, 7]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[1931, 7]]}, "issue": "3"}, "alternative-id": ["S0031182000013718"], "URL": "http://dx.doi.org/10.1017/s0031182000013718", "relation": {"cites": []}, "ISSN": ["0031-1820", "1469-8161"], "issn-type": [{"value": "0031-1820", "type": "print"}, {"value": "1469-8161", "type": "electronic"}], "subject": ["Animal Science and Zoology", "Parasitology", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:16:42Z", "timestamp": 1574158602031}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1977, 1, 1]], "date-time": "1977-01-01T00:00:00Z", "timestamp": 220924800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Comparative Biochemistry and Physiology Part A: Physiology"], "published-print": {"date-parts": [[1977, 1]]}, "DOI": "10.1016/0300-9629(77)90238-9", "type": "journal-article", "created": {"date-parts": [[2003, 3, 25]], "date-time": "2003-03-25T14:55:35Z", "timestamp": 1048604135000}, "page": "283-286", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Factors affecting meal to pellet intervals in great-horned owls (Bubo virginianus)"], "prefix": "10.1016", "volume": "56", "author": [{"given": "G.E.", "family": "Duke", "sequence": "first", "affiliation": []}, {"given": "D.D.", "family": "Rhoades", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Comparative Biochemistry and Physiology Part A: Physiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0300962977902389?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0300962977902389?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 24]], "date-time": "2019-03-24T18:26:33Z", "timestamp": 1553451993000}, "score": 19.66983, "issued": {"date-parts": [[1977, 1]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1977, 1]]}, "issue": "3"}, "alternative-id": ["0300962977902389"], "URL": "http://dx.doi.org/10.1016/0300-9629(77)90238-9", "ISSN": ["0300-9629"], "issn-type": [{"value": "0300-9629", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:34:59Z", "timestamp": 1574469299754}, "reference-count": 46, "publisher": "Informa Healthcare", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Investigational Drugs"], "published-print": {"date-parts": [[2012, 6]]}, "DOI": "10.1517/13543784.2012.679341", "type": "journal-article", "created": {"date-parts": [[2012, 4, 16]], "date-time": "2012-04-16T11:00:28Z", "timestamp": 1334574028000}, "page": "861-869", "source": "Crossref", "is-referenced-by-count": 13, "title": ["A potential role for nilotinib inKIT-mutated melanoma"], "prefix": "10.1517", "volume": "21", "author": [{"given": "An", "family": "Tran", "sequence": "first", "affiliation": []}, {"given": "Hussein A", "family": "Tawbi", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2012, 4, 16]]}, "reference": [{"key": "CIT0001", "DOI": "10.3322/caac.20073", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1200/JCO.2009.23.4799", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1200/JCO.2004.04.165", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1200/JCO.2006.06.0483", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1093/annonc/mdj138", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Middleton MR", "volume": "18", "first-page": "158", "year": "2000", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2000.18.1.158", "doi-asserted-by": "crossref"}, {"key": "CIT0008", "author": "Parkinson DR", "volume": "8", "first-page": "1650", "year": "1990", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1990.8.10.1650", "doi-asserted-by": "crossref"}, {"key": "CIT0009", "DOI": "10.2165/00128071-200304050-00004", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1056/NEJMoa1104621", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1200/JCO.2006.06.0442", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1056/NEJMoa1002011", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "author": "Ribas A", "volume": "29", "first-page": "abstract 8509", "year": "2011", "journal-title": "J Clin Oncol", "DOI": "10.1200/jco.2011.29.15_suppl.8509", "doi-asserted-by": "crossref"}, {"key": "CIT0015", "DOI": "10.1056/NEJMoa1103782", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1056/NEJMra044389", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1126/science.279.5350.577", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1200/JCO.2006.06.2984", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1002/ijc.22681", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1200/JCO.2004.10.125", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1002/cncr.21064", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1016/j.humpath.2005.03.015", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1200/JCO.2007.14.0707", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1002/cncr.21834", "doi-asserted-by": "publisher"}, {"issue": "717", "key": "CIT0025", "doi-asserted-by": "crossref", "first-page": "abstract 7528", "DOI": "10.1200/jco.2004.22.14_suppl.7528", "volume": "22", "author": "Eton O", "year": "2004", "journal-title": "J Clin Oncol"}, {"key": "CIT0026", "DOI": "10.1038/sj.bjc.6602529", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1001/jama.2011.746", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1200/JCO.2010.33.9275", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1200/JCO.2007.12.7837", "doi-asserted-by": "publisher"}, {"issue": "15", "key": "CIT0030", "first-page": "abstract 9019", "volume": "27", "author": "Woodman SE", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "CIT0031", "DOI": "10.1002/cncr.25766", "doi-asserted-by": "publisher"}, {"issue": "15", "key": "CIT0032", "doi-asserted-by": "crossref", "first-page": "TPS312", "DOI": "10.1200/jco.2010.28.15_suppl.tps312", "volume": "28", "author": "Kalinsky K", "year": "2010", "journal-title": "Journal of Clinical Oncology"}, {"key": "CIT0033", "author": "Cho JH", "year": "2011", "journal-title": "Invest New Drugs"}, {"key": "CIT0034", "DOI": "10.1002/cncr.26120", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1592/phco.28.11.1374", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1056/NEJMoa055104", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1182/blood-2007-03-080689", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "author": "Manley PW", "volume": "48", "first-page": "abstract 3249", "year": "2007", "journal-title": "Proc Am Assoc Cancer Res"}, {"key": "CIT0039", "DOI": "10.1182/blood-2007-03-080689", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1056/NEJMoa0912614", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1159/000091943", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1038/clpt.2009.208", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1158/1535-7163.MCT-09-1181", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1016/S1470-2045(11)70201-7", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1158/1078-0432.CCR-04-2245", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1097/PDM.0b013e3181eb931b", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1186/1479-5876-8-117", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1158/0008-5472.CAN-08-4004", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Investigational Drugs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.679341", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 27]], "date-time": "2019-06-27T10:30:22Z", "timestamp": 1561631422000}, "score": 19.586967, "issued": {"date-parts": [[2012, 4, 16]]}, "references-count": 46, "journal-issue": {"published-online": {"date-parts": [[2012, 5, 11]]}, "published-print": {"date-parts": [[2012, 6]]}, "issue": "6"}, "alternative-id": ["10.1517/13543784.2012.679341"], "URL": "http://dx.doi.org/10.1517/13543784.2012.679341", "relation": {"cites": []}, "ISSN": ["1354-3784", "1744-7658"], "issn-type": [{"value": "1354-3784", "type": "print"}, {"value": "1744-7658", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:19:54Z", "timestamp": 1574158794167}, "reference-count": 20, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1979, 1, 1]], "date-time": "1979-01-01T00:00:00Z", "timestamp": 283996800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Comparative Biochemistry and Physiology Part A: Physiology"], "published-print": {"date-parts": [[1979, 1]]}, "DOI": "10.1016/0300-9629(79)90082-3", "type": "journal-article", "created": {"date-parts": [[2003, 3, 25]], "date-time": "2003-03-25T22:17:26Z", "timestamp": 1048630646000}, "page": "439-443", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Regulation of pellet egestion: The effects of multiple feedings on meal to pellet intervals in great horned owls"], "prefix": "10.1016", "volume": "62", "author": [{"given": "Mark R", "family": "Fuller", "sequence": "first", "affiliation": []}, {"given": "Gary E", "family": "Duke", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Comparative Biochemistry and Physiology Part A: Physiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0300962979900823?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0300962979900823?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 24]], "date-time": "2019-03-24T12:55:00Z", "timestamp": 1553432100000}, "score": 19.50481, "issued": {"date-parts": [[1979, 1]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[1979, 1]]}, "issue": "2"}, "alternative-id": ["0300962979900823"], "URL": "http://dx.doi.org/10.1016/0300-9629(79)90082-3", "ISSN": ["0300-9629"], "issn-type": [{"value": "0300-9629", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:50:34Z", "timestamp": 1574797834443}, "publisher-location": "London", "reference-count": 0, "publisher": "Palgrave Macmillan UK", "isbn-type": [{"value": "9781349430390", "type": "print"}, {"value": "9780230006133", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003]]}, "DOI": "10.1057/9780230006133_2", "type": "book-chapter", "created": {"date-parts": [[2016, 5, 19]], "date-time": "2016-05-19T03:29:59Z", "timestamp": 1463628599000}, "page": "31-55", "source": "Crossref", "is-referenced-by-count": 0, "title": ["1980\u20136: Prelude to Policy Development"], "prefix": "10.1057", "author": [{"given": "Karen", "family": "Duke", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Drugs, Prisons and Policy-Making"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1057/9780230006133_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 5, 19]], "date-time": "2016-05-19T03:30:01Z", "timestamp": 1463628601000}, "score": 19.3311, "issued": {"date-parts": [[2003]]}, "ISBN": ["9781349430390", "9780230006133"], "references-count": 0, "URL": "http://dx.doi.org/10.1057/9780230006133_2"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}